Phase 1 Addiction Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Nalmefene Implant in Healthy Subjects

Opioid Abuse and Addiction

ReacX Pharmaceuticals, Inc.24 enrolled1 locationNCT07325279

Completed

Phase 1

A Pharmacokinetic and Safety Study of the Chrono Nicotine Replacement Therapy System in male smokers.

cigarette addiction

Chrono Therapeutics Australia PTY LTD12 enrolled1 locationACTRN12615000304538

Not Yet Recruiting

Phase 1

Disulfiram for the treatment of crack dependence. A pilot study.

crack cocaine addiction

Laboratorio de Estudos em Neurociencias Aplicadas (LENA)30 enrolled1 locationACTRN12611000103965